XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Organization and Nature of Operations (Details) - Schedule of Condensed Consolidated Financial Statements - Avalon GloboCare Corp [Member]	6 Months Ended
	Jun. 30, 2024
Avalon Healthcare System, Inc. (“AHS”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	May 18, 2015
Percentage of Ownership	100.00%
Principal Activities	Holding company for payroll and other expenses
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	Feb. 07, 2017
Percentage of Ownership	100.00%
Principal Activities	Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	Apr. 29, 2016
Percentage of Ownership	100.00%
Principal Activities	Is not considered an operating entity
Genexosome Technologies Inc. (“Genexosome”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	Jul. 31, 2017
Percentage of Ownership	60.00%
Principal Activities	No current activities to report, dormant
Avactis Biosciences Inc. (“Avactis”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	Jul. 18, 2018
Percentage of Ownership	60.00%
Principal Activities	Dormant, is in process of being dissolved
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	May 08, 2020
Percentage of Ownership	100.00%
Principal Activities	Dormant, is in process of being dissolved
Avalon Laboratory Services, Inc. (“Avalon Lab”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	Oct. 14, 2022
Percentage of Ownership	100.00%
Principal Activities	Laboratory holding company with a 40% membership interest in Lab Services MSO
Q&A Distribution LLC (“Q&A Distribution”) [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Place and Date of Incorporation	May 01, 2024
Percentage of Ownership	100.00%
Principal Activities	Distributes KetoAir device

X

- Definition

Description of business purpose of the subsidiary of the limited liability company or limited partnership, for example, its day-to-day operating functions and whether it acts as a holding or operating company.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Date the subsidiary of the limited liability company (LLC) or limited partnership (LP) was formed, in YYYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_ConsolidatedEntitiesAxis=avco_AvalonGloboCareCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvalonHealthcareSystemIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvalonRT9PropertiesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvalonShanghaiHealthcareTechnologyCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_GenExosomeTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvactisBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvactisNanjingBiosciencesLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_AvalonLaboratoryServicesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=avco_QADistributionLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: